Oddo BHF - DASSAULT SYSTEMES SA (DSY) Dassault Systèmes : Medidata Next 2024: expansion de l’offre pour renouer avec la croissance à deux chiffres en 2026

Report

Oddo BHF

Nicolas David

Dassault Systèmes : Medidata Next 2024: expansion de l’offre pour renouer avec la croissance à deux chiffres en 2026

>Accélération de l’expansion du portefeuille de solutions de Medidata - Medidata tient cette semaine sa conférence commerciale annuelle, Medidata Next à New York, avec une keynote inaugurale tenue hier (principaux speakers : le CEO de Medidata Anthony Costello, nommé en mars dernier, le CTO de Medidata, ainsi que Bernard Charlès, Executive Chairman et Tarek Sherif co-fondateur de Medidata, désormais Chairman du vertical Lifescience). La société a ensuite organisé une ...

14/11/2024 1 FR

Underlying

DASSAULT SYSTEMES SA

See profile

FR0014003TT8 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Nicolas David

Other Reports on these Companies

Oddo BHF

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/14/2024

...

8h / 16m 8h / 16m 1 EN

Oddo BHF

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 14/11/2024

...

8h / 32m 8h / 32m 1 FR

Oddo BHF

Dassault Systemes : Medidata Next 2024: extending the offering to return to double-digit growth in 2026

>Ramp-up in the expansion of Medidata’s solutions portfolio - This week Medidata is holding its annual commercial conference, Medidata Next in New York, with the inaugural keynote speech taking place yesterday (main speakers: CEO of Medidata Anthony Costello, appointed in March, the CTO of Medidata, as well as Bernard Charlès, Executive Chairman and Tarek Sherif, the co-founder of Medidata and now chairman of the Lifescience vertical). The company then organised a ser...

9h / 38m 9h / 38m 1 EN

Accelleron : Straight and smooth sailing with a compounder profile

Swiss-based Accelleron was formed from the spin-off of ABB’s highly profitable turbocharger division in 2022. We view the share as a promising investment on 1/ market leadership in an attractive niche, 2/ about ~40% ROCE, 3/ conversion of ~80% of EBITDA into cash, leading to fast deleveraging, and a solid base for shareholder remuneration (75% pay out), and 4/ strong long-term visibility linked to a ~75% service share, the bulk of which is recurring. Despite an already strong sto...

1h / 10m 1h / 10m 1 EN

Oliver Metzger ... (+2)

Oliver Metzger
Stephan Wulf

Dermapharm Holding SE : All divisions contribute to better-than-expected 9M figures

>A strong set of 9M figures beats expectations - 9M sales of € 890m (+3%) came in 1% above our (€ 886m) and 2% above the consensus compiled by the company of € 871m. Adjusted EBITDA of € 240m (-1%) is 5% above our estimates of € 229m and 8% above consensus of € 223m. The slightly lower profitability vs 9M 2023 (adjusted EBITDA margin of 27% vs 28%) still reflects the absence of sales from the extremely attractive contract with BioNTech, which still supported Q1 2023....

7h / 19m 7h / 19m 1 EN

Thijs Berkelder ... (+2)

Thijs Berkelder
Usama Tariq

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...

7h / 21m 7h / 21m 1 FR

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Dassault Systèmes : Medidata Next 2024: expansion de l’offre pour renouer avec la croissance à deux chiffres en 2026

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/14/2024

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 14/11/2024

Dassault Systemes : Medidata Next 2024: extending the offering to return to double-digit growth in 2026

Accelleron : Straight and smooth sailing with a compounder profile

Dermapharm Holding SE : All divisions contribute to better-than-expected 9M figures

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe